Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Healthcare and Social Assistance

>>

Business Opportunities and Investment Strategies for Global Pain Management Market


Business Opportunities and Investment Strategies for Global Pain Management Market 2023-2033

Report code: SDMRHE1703175 | Industry: Healthcare and Social Assistance | Published On: 2024-05-14


Opportunity and Strategy Analysis
This report focuses on identifying opportunities and strategies for investing in the global pain management market within the forecast period. It provides a complete analysis of the global market both quantitatively and qualitatively. The quantitative analysis includes market size and revenue data of the total demand, sub-markets, and regional/national levels throughout 2023-2033. Qualitative analysis depicts a full picture of market dynamics and trends including drivers, restraints and challenges, emerging products/market trends, and Porter’s Fiver Forces analysis.

Based on the market data and analysis, the report highlights Increasingly Attractive Segments (IAS) and business opportunities in each segmentation. Moreover, a systematic evaluation of Internal Risks (factors arising within the industry development) and External Risks (factors arising from the surrounding environments) is provided for the pain management industry and market. All the identified risk factors are measured quantitatively according to GMD’s novel numeric system, i.e. each risk is evaluated with GMD Risk Index Number (GMD RIN) and GMD Risk Intensity Level (GMD RIL). This in-depth risk assessment offers a comprehensive understanding of the current risk factors and their developing trends. Furthermore, this report concludes risk management strategies and Critical Success Factors (CSFs) to help companies make intelligence-based business decisions in the global pain management industry.

Market Coverage & Overview
The report is based on studies for 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. Considering impact of COVID-19 and regional conflicts such as Russia-Ukraine war, the trend and outlook of global market is forecast in optimistic, balanced, and conservative scenarios. In the balanced view, the global pain management market is expected to reach $146.1 billion by 2033, growing by 5.6% annually over the coming years.

Segmentation Analysis
Highlighted with 90 tables and 92 figures, this 179-page report represents a 360-degree view on the global market with extensively detailed segmentations by Offering, Application, Distribution Channel, and Region/Country as shown below. Annual revenue 2023-2033 for each segment is included in the report.

By Offering
• Drugs
o Opioids
o NSAIDS
o Anesthetics
o Anticonvulsants
o Anti-depressants
o Non-narcotic Analgesics
• Devices
o Neurostimulation Devices
 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
 Brain and Spinal Cord Stimulation (SCS) Devices
o Analgesic Infusion Pumps
 Intrathecal Infusion Pumps
 External Infusion Pumps

By Application
• Neuropathic Pain
• Cancer Pain
• Facial Pain and Migraine
• Musculoskeletal Pain
• Post-operative Pain
• Chronic Back Pain
• Arthritic Pain
• Other Applications

By Distribution Channel
• Hospitals Pharmacy
• Online Pharmacy
• Retail Pharmacy

By Region
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, and Rest of MEA)
The breakdown of all regional markets by country and the breakdown of each national market by Offering, Application, and Distribution Channel over the forecast years are also included.

Key Companies
The report also covers the current competitive scenario and profiles key vendors including market leaders and important emerging players. A selection of companies profiled in this report includes:
• Abbott Laboratories Inc.
• Baxter International Inc.
• Becton, Dickinson and Company
• Boehringer Ingelheim International GmbH
• Boston Scientific Corporation
• Eli Lilly & Company
• Endo Health Solutions, Inc.
• Fresenius SE & Co. KGaA
• GlaxoSmithKline PLC
• Johnson & Johnson
• Medtronic PLC
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• Purdue Pharma L.P
• Teva Pharmaceutical Industries Ltd.

1  Introduction 9
1.1  Industry  Definition  and  Research  Scope 9
1.1.1  Industry  Definition 9
1.1.2  Research  Scope 10
1.2  Research  Methodology 13
1.2.1  Overview  of  Market  Research  Methodology 13
1.2.2  Market  Assumption 14
1.2.3  Secondary  Data 14
1.2.4  Primary  Data 14
1.2.5  Data  Filtration  and  Model  Design 15
1.2.6  Market  Size/Share  Estimation 16
1.2.7  Research  Limitations 17
1.3  Executive  Summary 18
2  Market  Overview  and  Dynamics 20
2.1  Market  Size  and  Forecast 20
2.1.1  Impact  of  COVID-19  on  World  Economy 21
2.1.2  Impact  of  COVID-19  on  the  Market 25
2.1.3  Impact  of  Russia-Ukraine  Conflict 27
2.1.4  Impact  of  Israel-Palestine  War 29
2.2  Major  Growth  Drivers 30
2.3  Market  Restraints  and  Challenges 35
2.4  Emerging  Opportunities  and  Market  Trends 38
2.5  Porter’s  Fiver  Forces  Analysis 41
3  Segmentation  of  Global  Market  by  Offering 45
3.1  Market  Overview  by  Offering 45
3.2  Drugs 48
3.2.1  Opioids 50
3.2.2  NSAIDS 51
3.2.3  Anesthetics 52
3.2.4  Anticonvulsants 53
3.2.5  Anti-depressants 54
3.2.6  Non-narcotic  Analgesics 55
3.3  Devices 56
3.3.1  Neurostimulation  Devices 57
3.3.2  Analgesic  Infusion  Pumps 58
4  Segmentation  of  Global  Market  by  Application 59
4.1  Market  Overview  by  Application 59
4.2  Neuropathic  Pain 62
4.3  Cancer  Pain 63
4.4  Facial  Pain  and  Migraine 64
4.5  Musculoskeletal  Pain 65
4.6  Post-operative  Pain 66
4.7  Chronic  Back  Pain 67
4.8  Arthritic  Pain 68
4.9  Other  Applications 69
5  Segmentation  of  Global  Market  by  Distribution  Channel 70
5.1  Market  Overview  by  Distribution  Channel 70
5.2  Hospitals  Pharmacy 73
5.3  Online  Pharmacy 74
5.4  Retail  Pharmacy 75
6  Segmentation  of  Global  Market  by  Region 76
6.1  Geographic  Market  Overview  2023-2033 76
6.2  North  America  Market  2023-2033  by  Country 81
6.2.1  Overview  of  North  America  Market 81
6.2.2  U.S. 85
6.2.3  Canada 88
6.2.4  Mexico 90
6.3  European  Market  2023-2033  by  Country 92
6.3.1  Overview  of  European  Market 92
6.3.2  Germany 96
6.3.3  U.K. 98
6.3.4  France 100
6.3.5  Spain 102
6.3.6  Italy 104
6.3.7  Russia 106
6.3.8  Rest  of  European  Market 108
6.4  Asia-Pacific  Market  2023-2033  by  Country 110
6.4.1  Overview  of  Asia-Pacific  Market 110
6.4.2  Japan 114
6.4.3  China 117
6.4.4  Australia 119
6.4.5  India 121
6.4.6  South  Korea 123
6.4.7  Rest  of  APAC  Region 125
6.5  South  America  Market  2023-2033  by  Country 127
6.5.1  Argentina 131
6.5.2  Brazil 133
6.5.3  Chile 135
6.5.4  Rest  of  South  America  Market 137
6.6  MEA  Market  2023-2033  by  Country 138
6.6.1  UAE 142
6.6.2  Saudi  Arabia 144
6.6.3  South  Africa 146
6.6.4  Other  National  Markets 148
7  Competitive  Landscape 149
7.1  Overview  of  Key  Vendors 149
7.2  New  Product  Launch,  Partnership,  Investment,  and  M&A 152
7.3  Company  Profiles 153
Abbott  Laboratories  Inc. 153
Baxter  International  Inc. 155
Becton,  Dickinson  and  Company 156
Boehringer  Ingelheim  International  GmbH 157
Boston  Scientific  Corporation 158
Eli  Lilly  &  Company 159
Endo  Health  Solutions,  Inc. 160
Fresenius  SE  &  Co.  KGaA 161
GlaxoSmithKline  PLC 162
Johnson  &  Johnson 163
Medtronic  PLC 164
Merck  &  Co.  Inc. 165
Novartis  AG 166
Pfizer  Inc. 167
Purdue  Pharma  L.P 168
Teva  Pharmaceutical  Industries  Ltd. 169
8  Investing  in  Pain  Management  Industry:  Risk  Assessment  and  Management 170
8.1  Risk  Evaluation  of  Global  Market 170
8.2  Critical  Success  Factors  (CSFs) 176
RELATED  REPORTS 179
To know more, kindly contact [email protected]
 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT